BioMarin Revenue Tops $1 Billion as 2026 Outlook Is Lowered
Third-quarter revenue rose 32%, while the company reduced its full-year revenue and adjusted earnings guidance amid order timing uncertainty and acquisition-related charges.
Makkler Newsroom · Nov 3, 12:25 AM · 1 min read